Could a common drug ease ulcerative colitis Flare-Ups?
NCT ID NCT07349472
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if pentoxifylline, a drug already used for other conditions, can safely reduce symptoms of mild to moderate ulcerative colitis. About 60 adults will take the drug and be monitored for changes in bowel symptoms and quality of life. The goal is to see if this offers a new, simple treatment option without strong immune-suppressing drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fayoum University
RECRUITINGAl Fayyum, 54687, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a probiotic enema heal the gut lining in ulcerative colitis?
- Amniotic cell secretions may fight gut inflammation and scarring — a lab study puts them to the test
- Could a diet change calm IBD by reshaping gut bacteria?
- Experimental drug aims to quiet gut inflammation in ulcerative colitis
- Can a peer coach help young people take control of their chronic illness?
- Medical records reveal clues to treating stubborn inflammatory bowel disease